Sutrobio
2 known investors
Sutro develops a next-generation antibody-drug conjugate (ADC) platform for single- and dual-payload therapeutics aimed at treating cancer patients. It operates in the oncology-focused biotech and drug development industry.
BiotechHealthtech
Investors Β· 2
Frequently asked questions
- What does Sutrobio do?
- Sutro develops a next-generation antibody-drug conjugate (ADC) platform for single- and dual-payload therapeutics aimed at treating cancer patients. It operates in the oncology-focused biotech and drug development industry.
- Who are Sutrobio's investors?
- Sutrobio's investors include Owl Capital, Solasta Ventures.